Immunophenotypic analyses showed wide variations in the expression of PSGL-1, L-selectin, sLex, Lex and CLA determinants among ALL and AML while CD43 and CD44 levels were more constant (Figure 1). This evidence concerns the gene SELL and acute myeloid leukemia.